查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012469

ATP 檢測市場：按產品類型、技術、樣品類型和最終用戶分類 - 2026-2032 年全球市場預測

ATP Assays Market by Product Type, Technology, Sample Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計 ATP 檢測市場在 2025 年的價值為 6.1965 億美元，在 2026 年成長至 7.0508 億美元，到 2032 年達到 15.8593 億美元，年複合成長率為 14.36%。

主要市場統計數據
基準年 2025 6.1965億美元
預計年份：2026年 7.0508億美元
預測年份 2032 1,585,930,000 美元
複合年成長率 (%) 14.36%

全面介紹 ATP 檢測的原理、平台組成及其在診斷、環境監測和食品安全領域的實際價值。

三Adenosine腺苷 (ATP) 檢測在生物分析測試中發揮核心作用，因為它可以透過生化發光和光學檢測方法快速、高靈敏度地測量細胞活力和微生物污染。過去十年，檢測平台已從手動、固定的操作流程發展成為更自動化、整合化的解決方案，這些方案結合了儀器、試劑組和專業服務，能夠滿足各種實驗室和現場應用的需求。因此，臨床診斷、食品安全、環境監測和藥品品質保證等領域的相關人員越來越依賴 ATP 檢測作為初步篩檢或更廣泛診斷演算法的一部分。

ATP 檢測技術、自動化和監管整合的重大變革正在重塑各行業的採購、部署和數據驅動決策。

在ATP檢測領域，技術、操作和監管因素共同驅動多項變革，這些變革正在重新定義檢測方法的開發、應用和商業化方式。技術方面，基於螢火蟲和細菌來源的螢光素酶化學反應的發光檢測方法在靈敏度方面仍然佔據主導地位，而螢光和比色法等互補的光學方法則實現了多重檢測和現場檢測。攜帶式發光儀和小型微孔盤讀數儀的成熟縮小了集中式實驗室和現場檢測之間的差距。因此，對於那些必須在處理能力和移動性之間取得平衡的機構而言，採購重點正在轉變。

評估 2025 年關稅措施如何重塑整個 ATP 檢測價值鏈的供應鏈韌性、籌資策略和生產力經濟。

美國於2025年實施的關稅措施的累積影響，已對整個ATP檢測價值鏈產生了一系列複雜的下游效應，波及組件採購、製造成本和籌資策略等各個環節。依賴進口光學元件、感測器組件或試劑前驅物的供應商面臨更高的到貨成本，迫使一些製造商重新評估與供應商的契約，並探索其他採購途徑。這種衝擊正在加速關於近岸外包和本地組裝的討論，以降低關稅波動帶來的風險，並縮短關鍵儀器組件的前置作業時間。

基於細分的關鍵見解揭示了產品類型、檢測技術、最終用戶要求和樣品基質如何決定 ATP 檢測的引入和性能優先順序。

深入的市場細分揭示了ATP檢測市場中性能、應用和創新壓力集中的領域，並突出了戰略投資最有可能帶來最高營運效益的領域。依產品類型分析，微孔盤讀數儀和可攜式發光儀等儀器各自服務不同的應用場景。微孔盤讀數儀在需要進行多項分析的高通量實驗室中表現出色，而可攜式發光儀則可實現快速現場篩檢和現場決策。試劑組也呈現類似的兩極化。自動化試劑盒針對與機器人工作流程和高通量環境的整合進行了最佳化，而手動試劑盒則繼續用於小規模實驗室以及優先考慮柔軟性和成本控制的環境中。合約測試和客製化檢測開發等服務產品為擴展專業知識提供了途徑，而無需前期投資於儀器或檢測驗證。

深入分析不同管理體制、基礎設施成熟度和供應鏈部署如何影響主要全球區域 ATP 檢測方法的採用。

區域趨勢明顯影響美洲、歐洲、中東和非洲以及亞太地區ATP檢測的需求促進因素、監管預期和技術應用模式。在美洲，分散式檢查模式和完善的通路支援可攜式和實驗室級平台。同時，監管機構對食品安全和醫院認證的重視推動了對已驗證檢測方法以及與電子病歷系統整合的需求。而歐洲和中東及非洲的情況則更為複雜。歐洲部分地區的監管協調正在推進，而其他地區的基礎設施狀況則存在差異，導致高通量儀器和小型現場檢測設備的普及速度有所不同。

這提供了關鍵的、企業級的見解，了解產品創新、服務專業化和策略夥伴關係關係如何決定 ATP 檢測生態系統中的競爭優勢。

ATP檢測領域的競爭動態日益受到產品創新、服務多元化和策略夥伴關係的影響。領先的儀器製造商正致力於小型化、提升光學性能和軟體整合，以提供可操作的分析結果，從而減少對操作人員的依賴。同時，試劑盒供應商則著力提升試劑穩定性、簡化工作流程並增強與自動化系統的兼容性，以滿足高通量檢查室和現場檢測的需求。提供合約檢測和客製化檢測開發的服務供應商正利用市場對外包驗證和快速檢測法部署的需求，將自身定位為客戶研發和品質保證能力的延伸。

為產業領導者提供切實可行的建議，以增強供應鏈韌性，透過模組化設計和服務加速部署，並加強監管應對力。

產業領導者若想鞏固自身在ATP檢測領域的地位和韌性，應採取一系列戰術性和策略舉措，旨在應對價值鏈風險、加速產品應用並提升價值獲取。首先，供應商多元化和二級組件來源的合格能夠降低貿易中斷帶來的風險，確保生產和試劑供應的連續性。同時，推廣模組化產品架構，使儀器、試劑盒和軟體能夠單獨進行重新配置或升級，將縮短新應用情境的上市時間，並使企業無需進行大規模的合格即可回應客戶需求。

透明的調查方法結合了二手技術資訊來源、與關鍵相關人員的訪談以及嚴格的三角檢驗，從而得出基於證據的 ATP 檢測見解。

本分析的研究途徑結合了結構化的二手資料研究、與關鍵相關人員的訪談以及嚴格的交叉檢驗，以確保結論既反映技術實際情況，也反映商業性趨勢。二級資訊來源包括同行評審的分析化學表徵文獻、儀器性能技術應用說明、監管指導文件以及闡明產品分類和應用案例要求的行業報告。一手資料研究則包括與實驗室經理、品質保證經理、儀器工程師、試劑開發人員和服務供應商的深入訪談，以直接了解營運挑戰、驗證實務和採購重點。

簡明結論總結了技術能力、監管合規性和供應鏈韌性如何決定 ATP 檢測的採用和長期相關人員價值。

ATP 檢測正處於一個轉折點，受到技術進步、用戶期望不斷變化以及貿易政策等外部壓力等多方面因素的影響，這些因素正在影響 ATP 檢測的普及速度和方向。從可攜式發光儀到高通量微孔盤，從涵蓋手動到自動化工作流程的試劑組形式，到包括合約測試和客製化檢測開發在內的服務模式，各種儀器的功能相互作用，構建了一個模組化的生態系統，可以根據學術界、工業界、臨床和監管機構等不同用戶的需求進行客製化。不同檢測技術之間的靈敏度差異，特別是發光技術（如螢火蟲和細菌螢光素酶）的差異，以及螢光和比色法等互補方法，使得解決方案設計者能夠根據操作限制和樣品基質挑戰，合理地匹配分析性能。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 ATP 檢測市場：依產品類型分類

  • 裝置
    • 微孔盤讀數儀
    • 可攜式照度計
  • 成套工具
    • 自動套件
    • 手冊套件
  • 服務
    • 合約測試
    • 客製化檢測開發

第9章 ATP 檢測市場：依技術分類

  • 比色法
  • 螢光法
  • 發光法
    • 細菌螢光素酶
    • 螢火蟲螢光素酶

第10章檢體類型分類的ATP檢測市場

  • 血
  • 食物
  • 土壤
  • 拭子檢體
  • 水

第11章 ATP 檢測市場：依最終用戶分類

  • 學術研究機構
  • 環保組織
  • 食品和飲料公司
  • 醫院和診斷檢測機構
  • 製藥和生物技術

第12章 ATP 檢測市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 ATP 檢測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 ATP 檢測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國ATP檢測市場

第16章：中國ATP檢測市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • AAT Bioquest, Inc.
  • Abcam plc
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioThema AB
  • Biotium, Inc.
  • Canvax Biotech SL
  • Cayman Chemical Company
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • Hygiena LLC
  • Kikkoman Biochemifa Co., Ltd.
  • Lonza Group Ltd.
  • Merck KGaA
  • Neogen Corporation
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-434301986952

The ATP Assays Market was valued at USD 619.65 million in 2025 and is projected to grow to USD 705.08 million in 2026, with a CAGR of 14.36%, reaching USD 1,585.93 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 619.65 million
Estimated Year [2026] USD 705.08 million
Forecast Year [2032] USD 1,585.93 million
CAGR (%) 14.36%

A comprehensive introduction to ATP assay principles, platform components, and practical value across diagnostics, environmental monitoring, and food safety applications

Adenosine triphosphate (ATP) assays occupy a central role in bioanalytical testing by providing a rapid, sensitive measure of cellular viability and microbial contamination through biochemical luminescence and optical detection methods. Over the past decade, assay platforms have matured from bench-bound manual workflows to more automated, integrated solutions that combine instrumentation, reagent kits, and professional services to meet a wide range of laboratory and field applications. As a result, stakeholders across clinical diagnostics, food safety, environmental monitoring, and pharmaceutical quality assurance increasingly rely on ATP measures as an initial screen or as a component of broader testing algorithms.

The modern ATP assay ecosystem encompasses a continuum of product types, including instruments such as microplate readers and portable luminometers, reagent kits that range from manual to automated formats, and services that include contract testing and custom assay development. Each element contributes to a faster time-to-result, improved reproducibility, and a reduction in manual error, while also raising expectations for integration with laboratory information management systems and digital data capture. This introduction frames ATP assays not merely as standalone tests but as modular capabilities that laboratories and organizations assemble to meet specific throughput, portability, and regulatory requirements.

Looking forward, ATP assays are being shaped by advances in detection chemistries, miniaturized optics, and software-enabled analytics that facilitate decision-making at the point of care or in remote field operations. Consequently, adopters must balance considerations of sensitivity, ease of use, and total cost of ownership as they select from instruments, kits, and service options. The following sections examine the transformative shifts, regulatory and trade pressures, segmentation nuances, regional dynamics, competitive behaviors, actionable recommendations, research methodology, and concluding perspectives that collectively inform strategic choices for stakeholders engaged with ATP assay solutions.

Critical transformative shifts in ATP assay technologies, automation, and regulatory integration that are reshaping procurement, deployment, and data-driven decision-making across sectors

The ATP assay landscape is undergoing several transformative shifts driven by technological, operational, and regulatory forces that are redefining how assays are developed, deployed, and commercialized. On the technological front, luminescence-based detection-driven by luciferase chemistries including firefly and bacterial variants-continues to lead in sensitivity, while complementary optical modalities such as fluorescence and colorimetry enable multiplexed and contextual measurements. Portable luminometers and compact microplate readers have matured, shrinking the gap between centralized laboratories and point-of-need testing, which in turn is altering procurement priorities for organizations that must balance throughput with mobility.

Operationally, automation is elevating the role of kit design and instrument interoperability; automated kits reduce hands-on time and variability, enabling higher sample throughput and more consistent data quality. Simultaneously, demand for services such as contract testing and bespoke assay development is rising as organizations outsource specialized capabilities to mitigate capital expenditures and accelerate validation timelines. Suppliers are responding by bundling instruments, validated kits, and ongoing service contracts to deliver turnkey solutions that shorten adoption cycles.

Regulatory and quality expectations are also shifting; greater emphasis on traceability, chain-of-custody, and digital record-keeping is prompting manufacturers to embed connectivity and compliance-ready features into instruments and software. These changes encourage closer collaboration between assay developers and end users in academic, clinical, industrial, and regulatory settings. Moreover, the convergence of miniaturized optics, improved luciferase formulations, and cloud-enabled analytics is enabling more real-time decision support, which changes how public health entities, food processors, and environmental agencies act on ATP-derived signals. Taken together, these forces are accelerating a transition from isolated assays to integrated testing ecosystems that prioritize scalability, regulatory alignment, and actionable intelligence.

Assessment of how 2025 tariff measures reshaped supply chain resilience, sourcing strategies, and production economics across the ATP assay value chain

The cumulative impact of the United States tariff measures implemented in 2025 has created a complex set of downstream effects across the ATP assay value chain, with implications for component sourcing, manufacturing economics, and procurement strategies. Suppliers that rely on imported optics, sensor components, or reagent precursors have faced higher landed costs, prompting some manufacturers to re-evaluate supplier contracts and to explore alternative sourcing corridors. These disruptions have accelerated conversations about nearshoring and localized assembly to reduce exposure to tariff volatility and to shorten lead times for critical instrument components.

Consequently, procurement teams and laboratory managers have adopted a range of adaptive measures, including renegotiated supply agreements, inventory buffering, and a more explicit assessment of total cost of ownership that factors in tariffs, freight, and customs handling. In parallel, service providers offering contract testing and custom assay development have seen both challenges and opportunities: while some operational costs have risen, those organizations that can demonstrate domestic capacity or tariff-resilient workflows have become more attractive partners for customers seeking continuity of supply.

At the innovation front, manufacturers are exploring design optimizations that reduce dependence on tariff-sensitive components, and some have accelerated investment in alternative luciferase suppliers and reagent chemistry that can be sourced more flexibly. This period has also underscored the strategic value of product modularity-where instruments and kits can be recombined or requalified with different supplier inputs-to preserve functionality while adapting to input cost fluctuations. Overall, the 2025 tariff environment has highlighted the need for enhanced supply chain transparency, scenario planning, and vendor risk management across the ATP assay ecosystem.

Key segmentation-driven insights revealing how product types, detection technologies, end-user requirements, and sample matrices determine ATP assay adoption and performance priorities

Insightful segmentation reveals where performance, adoption, and innovation pressures concentrate within the ATP assay market and clarifies where strategic investments are most likely to yield operational benefits. When analyzed by product type, instruments-including microplate readers and portable luminometers-serve distinct use cases; microplate readers excel in high-throughput laboratories that require multiplexed analyses, whereas portable luminometers enable rapid field screening and on-site decision-making. Reagent kits present a similar bifurcation: automated kits are optimized for integration with robotic workflows and high-throughput environments, while manual kits continue to serve smaller labs or settings where flexibility and cost control are priorities. Service offerings such as contract testing and custom assay development provide pathways to scale expertise without the upfront capital investment in instruments and assay validation.

Examining the technology dimension, luminescence-based assays remain the gold standard for sensitivity and are further differentiated by luciferase type; firefly luciferase often underpins assays requiring high signal intensity and broad dynamic range, while bacterial luciferase formulations can offer alternative kinetics or substrate profiles that suit specific applications. Fluorescence and colorimetry technologies complement luminescence in contexts demanding multiplexing or where luminescent reagents are impractical. This technological layering enables end users to select solutions that balance sensitivity, cost, and operational complexity.

From an end-user perspective, academic research institutes prioritize assay flexibility and methodological transparency to support exploratory experiments and method development. Environmental monitoring agencies emphasize ruggedness and field-proven portability for rapid contamination screening in varied sample matrices. Food and beverage companies focus on throughput and regulatory-compliant documentation to support routine sanitation verification. Hospitals and diagnostic laboratories require validated workflows that integrate with quality systems and patient-care timetables, while pharmaceutical and biotechnology firms demand assay robustness for process development and quality control. Sample type further influences solution selection; blood matrices require rigorous validation for matrix effects and interference, food products demand methods tolerant of complex matrices and sample preparation variability, soil and water testing call for instruments and kits adapted to particulate or organic load, and swab samples necessitate extraction and recovery efficiency considerations that influence kit chemistry and instrument sensitivity. Synthesizing these segmentation lenses clarifies how product, technology, end-user, and sample type interact to define adoption pathways and technical priorities for stakeholders.

Critical regional insights on how differing regulatory regimes, infrastructure maturity, and supply chain footprints shape ATP assay adoption across major global regions

Regional dynamics exert distinct influences on demand drivers, regulatory expectations, and technology adoption patterns for ATP assays across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, decentralized testing models and robust distribution channels support both portable and laboratory-grade platforms, while regulatory emphasis on food safety and hospital accreditation drives demand for validated assays and integration with electronic record systems. Transitioning across to Europe, the Middle East & Africa, there is a heterogeneous landscape where regulatory harmonization in parts of Europe contrasts with variable infrastructure in other regions, creating differentiated adoption curves for high-throughput instruments versus compact point-of-need devices.

In the Asia-Pacific region, rapid industrialization and expansion of contract research and manufacturing services have stimulated demand for both instruments and service offerings, with particular emphasis on cost-effective automation and scalability. Manufacturers often prioritize localized support, training, and service networks in these markets to address diverse user competencies and to accelerate method adoption. Across all regions, interoperability, ease of validation, and after-sales service capabilities emerge as critical selection criteria, and suppliers that can align their product roadmaps with regional regulatory frameworks and procurement cycles tend to gain market traction. Moreover, regional supply chain structures influence lead times and resiliency; therefore, stakeholders evaluate regional manufacturing footprints, distributor partnerships, and localized reagent sourcing when formulating deployment strategies.

Key company-level insights showing how product innovation, service specialization, and strategic partnerships are defining competitive advantage in the ATP assay ecosystem

Competitive dynamics within the ATP assay space are increasingly shaped by a blend of product innovation, service diversification, and strategic partnerships. Leading instrument manufacturers are focused on miniaturization, enhanced optical performance, and software integration to deliver actionable analytics that reduce operator dependency. At the same time, kit suppliers are investing in reagent stability, simplified workflows, and automation compatibility to meet the needs of high-throughput laboratories and point-of-need testing scenarios. Service providers offering contract testing and custom assay development are capitalizing on demand for outsourced validation and rapid method translation, positioning themselves as extensions of customer R&D and quality assurance functions.

Partnerships between instrument vendors, kit manufacturers, and service laboratories are becoming more common, as combined offerings reduce barriers to adoption and provide end users with validated, turnkey workflows. Strategic moves such as regional manufacturing partnerships, distribution alliances, and co-development agreements help companies address tariff-related pressures and local regulatory requirements while enhancing responsiveness to customer needs. Additionally, investment in training, field support, and digital tools for data management and compliance is differentiating those companies that can support long-term customer success from those that compete predominantly on price. Ultimately, competitive advantage accrues to firms that can couple robust instrumentation and reagent portfolios with scalable, verifiable service delivery and regulatory support.

Actionable recommendations for industry leaders to build supply chain resilience, accelerate adoption through modular design and services, and strengthen regulatory readiness

Industry leaders seeking to strengthen position and resilience in the ATP assays domain should pursue a combination of tactical and strategic initiatives designed to address supply chain risk, accelerate adoption, and enhance value capture. First, diversifying supplier bases and qualifying secondary component sources can mitigate exposure to trade disruptions and enable continuity in manufacturing and reagent supply. In parallel, advancing modular product architectures-where instruments, kits, and software can be recombined or upgraded independently-reduces time-to-market for new use cases and allows organizations to respond to customer needs without extensive requalification.

Second, investing in automation and validated kit formats can lower total cost of ownership for high-throughput customers while preserving margins through value-added services such as assay validation, training, and data management. Collaboration with contract testing and custom assay development providers is a pragmatic route to expanding service capacity and entering adjacent markets without heavy capital commitments. Third, embedding connectivity and compliance-ready features into instruments and software helps customers meet regulatory expectations related to traceability and digital record-keeping, thereby creating a compelling proposition for clinical and industrial adopters. Finally, engaging proactively with policymakers and industry consortia to clarify tariff impacts, standards, and validation guidelines can reduce friction for commercial adoption and support more stable operating conditions. By executing across these dimensions, leaders can simultaneously improve operational resilience and create differentiated, defensible offerings for diverse end users.

Transparent research methodology combining secondary technical sources, primary stakeholder interviews, and rigorous triangulation to produce evidence-based ATP assay insights

The research approach underpinning this analysis combined structured secondary research, primary stakeholder interviews, and rigorous cross-validation to ensure conclusions reflect both technical realities and commercial dynamics. Secondary sources included peer-reviewed literature on assay chemistries, technical application notes on instrument performance, regulatory guidance documents, and industry reports that clarify product classifications and use-case requirements. Primary research entailed in-depth conversations with laboratory directors, quality assurance managers, instrument engineers, reagent formulators, and service providers to capture firsthand insights into operational pain points, validation practices, and procurement priorities.

Data triangulation was applied to reconcile themes emerging from qualitative interviews with technical specifications and documented regulatory requirements. Attention was given to ensuring methodological transparency: interview protocols were standardized, and technical claims were cross-checked against published performance data and vendor specifications. Limitations and scope boundaries were explicitly noted to contextualize findings, including the focus on assay functionalities, product ecosystems, regional dynamics, and trade-related impacts rather than providing financial estimations. Together, this methodology supports actionable insights while maintaining defensible, evidence-based conclusions for stakeholders evaluating ATP assay technologies and strategies.

A concise conclusion synthesizing how technological capability, regulatory alignment, and supply chain resilience will determine ATP assay adoption and long-term stakeholder value

ATP assays are at an inflection point where technological advances, evolving user expectations, and external pressures such as trade policy intersect to influence the pace and direction of adoption. The interplay between instrument capabilities-ranging from portable luminometers to high-throughput microplate readers-reagent kit formats that span manual to automated workflows, and service models including contract testing and custom assay development creates a modular ecosystem that can be tailored to the diverse needs of academic, industrial, clinical, and regulatory users. Sensitivity differentials among detection technologies, particularly luminescence variants like firefly and bacterial luciferase, and complementary approaches such as fluorescence and colorimetry, enable solution architects to match analytical performance with operational constraints and sample matrix challenges.

In this environment, organizations that prioritize supply chain transparency, validation readiness, and customer-focused service models will be better positioned to convert technical capability into sustained adoption. The cumulative effects of trade-related disruptions have underscored the importance of supplier diversification and regional support networks, while automation and software-enabled compliance features remain critical levers for expanding addressable use cases. Ultimately, success in the ATP assay domain will favor those companies that can deliver integrated, validated workflows that reduce operational friction, enable rapid decision-making, and align product roadmaps with end-user validation and regulatory needs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. ATP Assays Market, by Product Type

  • 8.1. Instruments
    • 8.1.1. Microplate Readers
    • 8.1.2. Portable Luminometers
  • 8.2. Kits
    • 8.2.1. Automated Kits
    • 8.2.2. Manual Kits
  • 8.3. Services
    • 8.3.1. Contract Testing
    • 8.3.2. Custom Assay Development

9. ATP Assays Market, by Technology

  • 9.1. Colorimetry
  • 9.2. Fluorescence
  • 9.3. Luminescence
    • 9.3.1. Bacterial Luciferase
    • 9.3.2. Firefly Luciferase

10. ATP Assays Market, by Sample Type

  • 10.1. Blood
  • 10.2. Food Products
  • 10.3. Soil
  • 10.4. Swab Samples
  • 10.5. Water

11. ATP Assays Market, by End User

  • 11.1. Academic Research Institutes
  • 11.2. Environmental Agencies
  • 11.3. Food & Beverage Companies
  • 11.4. Hospitals & Diagnostic Laboratories
  • 11.5. Pharmaceutical & Biotechnology

12. ATP Assays Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. ATP Assays Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. ATP Assays Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States ATP Assays Market

16. China ATP Assays Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3M Company
  • 17.6. AAT Bioquest, Inc.
  • 17.7. Abcam plc
  • 17.8. Agilent Technologies, Inc.
  • 17.9. Bio-Rad Laboratories, Inc.
  • 17.10. BioThema AB
  • 17.11. Biotium, Inc.
  • 17.12. Canvax Biotech S.L.
  • 17.13. Cayman Chemical Company
  • 17.14. Cell Signaling Technology, Inc.
  • 17.15. Danaher Corporation
  • 17.16. Hygiena LLC
  • 17.17. Kikkoman Biochemifa Co., Ltd.
  • 17.18. Lonza Group Ltd.
  • 17.19. Merck KGaA
  • 17.20. Neogen Corporation
  • 17.21. PerkinElmer, Inc.
  • 17.22. Promega Corporation
  • 17.23. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ATP ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ATP ASSAYS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ATP ASSAYS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ATP ASSAYS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ATP ASSAYS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ATP ASSAYS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ATP ASSAYS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ATP ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ATP ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ATP ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ATP ASSAYS MARKET SIZE, BY MICROPLATE READERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ATP ASSAYS MARKET SIZE, BY MICROPLATE READERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ATP ASSAYS MARKET SIZE, BY MICROPLATE READERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ATP ASSAYS MARKET SIZE, BY PORTABLE LUMINOMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ATP ASSAYS MARKET SIZE, BY PORTABLE LUMINOMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ATP ASSAYS MARKET SIZE, BY PORTABLE LUMINOMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ATP ASSAYS MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ATP ASSAYS MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ATP ASSAYS MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ATP ASSAYS MARKET SIZE, BY AUTOMATED KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ATP ASSAYS MARKET SIZE, BY AUTOMATED KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ATP ASSAYS MARKET SIZE, BY AUTOMATED KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ATP ASSAYS MARKET SIZE, BY MANUAL KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ATP ASSAYS MARKET SIZE, BY MANUAL KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ATP ASSAYS MARKET SIZE, BY MANUAL KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ATP ASSAYS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ATP ASSAYS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ATP ASSAYS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ATP ASSAYS MARKET SIZE, BY CONTRACT TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ATP ASSAYS MARKET SIZE, BY CONTRACT TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ATP ASSAYS MARKET SIZE, BY CONTRACT TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ATP ASSAYS MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ATP ASSAYS MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ATP ASSAYS MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ATP ASSAYS MARKET SIZE, BY COLORIMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ATP ASSAYS MARKET SIZE, BY COLORIMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ATP ASSAYS MARKET SIZE, BY COLORIMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ATP ASSAYS MARKET SIZE, BY FLUORESCENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ATP ASSAYS MARKET SIZE, BY FLUORESCENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ATP ASSAYS MARKET SIZE, BY FLUORESCENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ATP ASSAYS MARKET SIZE, BY BACTERIAL LUCIFERASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ATP ASSAYS MARKET SIZE, BY BACTERIAL LUCIFERASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ATP ASSAYS MARKET SIZE, BY BACTERIAL LUCIFERASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ATP ASSAYS MARKET SIZE, BY FIREFLY LUCIFERASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ATP ASSAYS MARKET SIZE, BY FIREFLY LUCIFERASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ATP ASSAYS MARKET SIZE, BY FIREFLY LUCIFERASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ATP ASSAYS MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ATP ASSAYS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ATP ASSAYS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ATP ASSAYS MARKET SIZE, BY FOOD PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ATP ASSAYS MARKET SIZE, BY FOOD PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ATP ASSAYS MARKET SIZE, BY FOOD PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ATP ASSAYS MARKET SIZE, BY SOIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ATP ASSAYS MARKET SIZE, BY SOIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ATP ASSAYS MARKET SIZE, BY SOIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ATP ASSAYS MARKET SIZE, BY SWAB SAMPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ATP ASSAYS MARKET SIZE, BY SWAB SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ATP ASSAYS MARKET SIZE, BY SWAB SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ATP ASSAYS MARKET SIZE, BY WATER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ATP ASSAYS MARKET SIZE, BY WATER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ATP ASSAYS MARKET SIZE, BY WATER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ATP ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ATP ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ATP ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ATP ASSAYS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ATP ASSAYS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ATP ASSAYS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ATP ASSAYS MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ATP ASSAYS MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ATP ASSAYS MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ATP ASSAYS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ATP ASSAYS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ATP ASSAYS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ATP ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ATP ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ATP ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ATP ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS ATP ASSAYS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA ATP ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA ATP ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ATP ASSAYS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE ATP ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST ATP ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA ATP ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC ATP ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ATP ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN ATP ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. GCC ATP ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 168. GCC ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 170. GCC ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. GCC ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 172. GCC ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION ATP ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS ATP ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. G7 ATP ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 195. G7 ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 196. G7 ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 197. G7 ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. G7 ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 199. G7 ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. NATO ATP ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. NATO ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 204. NATO ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 205. NATO ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 206. NATO ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. NATO ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 208. NATO ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL ATP ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES ATP ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA ATP ASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA ATP ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA ATP ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA ATP ASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA ATP ASSAYS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA ATP ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA ATP ASSAYS MARKET SIZE, BY LUMINESCENCE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA ATP ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA ATP ASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)